Reproducibility of meal-induced transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease

被引:7
作者
Boeckxstaens, GE
Hirsch, DP
Verkleij, CB
Lei, A
Holman, R
Lehmann, A
Rydholm, H
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[3] AstraZeneca R&D Molndal, Molndal, Sweden
关键词
gastro-oesophageal reflux; gastro-oesophageal reflux disease; transient lower oesophageal sphincter relaxations; variability;
D O I
10.1111/j.1365-2982.2004.00610.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To calculate the number of subjects required in trials investigating drugs reducing the number of transient lower oesophageal sphincter relaxations (TLOSRs), the inter- and intra-individual variability of TLOSRs were determined, using meal ingestion as a trigger of TLOSRs and reflux. Methods: A total of 23 gastro-oesophageal reflux disease (GORD) patients with no to grade B oesophagitis and a hiatal hernia less than or equal to3 cm underwent oesophageal manometry and pHmetry 1 h before and 3 h after ingestion of a solid meal on two separate days approximately 4 weeks apart. Reflux episodes and the underlying mechanisms and the number of TLOSRs were evaluated. Results: The number of TLOSRs, reflux episodes and % time with pH < 4 after meal ingestion did not differ significantly between the two sessions. The intra-individual variation of TLOSRs in the 3 h postprandial period (24.4) was smaller compared with the inter-individual variation (47.5). Transient lower oesophageal sphincter relaxations were the predominant cause of reflux accounting for 61 +/- 7 and 70 +/- 5% of the reflux episodes in visits 1 and 2, respectively. Conclusions: These data for the first time provide information on the variability of TLOSRs and reflux evoked by meal ingestion, which is of crucial importance for the design and power calculations of future clinical studies evaluating the efficacy of new drugs targeting TLOSRs.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [41] Saliva variations in gastro-oesophageal reflux disease
    Campisi, G.
    Lo Russo, L.
    Di Liberto, C.
    Di Nicola, F.
    Butera, D.
    Vigneri, S.
    Compilato, D.
    Lo Muzio, L.
    Di Fede, O.
    JOURNAL OF DENTISTRY, 2008, 36 (04) : 268 - 271
  • [42] Prokinetics in the treatment of gastro-oesophageal reflux disease
    Heading, RC
    Baldi, F
    Holloway, RH
    Janssens, J
    Jian, R
    McCallum, RW
    Richter, JE
    Scarpignato, C
    Sontag, SJ
    Wienbeck, M
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (01) : 87 - 93
  • [43] Heartburn, gastro-oesophageal reflux disease and nonerosive reflux disease
    Smith, Haley
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (01) : 16 - 20
  • [44] Surgical therapy of gastro-oesophageal reflux disease
    Lundell, Lars
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (06) : 947 - 959
  • [45] Nonerosive reflux disease as a presentation of gastro-oesophageal reflux disease
    Simmonds, W. M.
    SOUTH AFRICAN FAMILY PRACTICE, 2011, 53 (04) : 326 - 331
  • [46] Gastro-oesophageal reflux disease: oesophageal impedance versus pH monitoring
    Vandenplas, Yvan
    Salvatore, Silvia
    Devreker, Thierry
    Hauser, Bruno
    ACTA PAEDIATRICA, 2007, 96 (07) : 956 - 962
  • [47] Increased gastro-oesophageal reflux disease in patients with severe COPD
    Casanova, C
    Baudet, JS
    Velasco, MD
    Martin, JM
    Aguirre-Jaime, A
    de Torres, JP
    Celli, BR
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 841 - 845
  • [48] Unsolved problems in the management of patients with gastro-oesophageal reflux disease
    Stanghellini, V
    Cogliandro, R
    Cogliandro, L
    De Giorgio, R
    Barbara, G
    Corinaldesi, R
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (12) : 843 - 848
  • [49] Dental and periodontal lesions in patients with gastro-oesophageal reflux disease
    Muñoz, JV
    Herreros, B
    Sanchiz, V
    Amoros, C
    Hernandez, V
    Pascual, I
    Mora, F
    Minguez, M
    Bagan, JV
    Benages, A
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (07) : 461 - 467
  • [50] Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease
    Jaspersen, D
    Schwacha, H
    Schorr, W
    Brennenstuhl, M
    Raschka, C
    Hammar, CH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (10) : 900 - 902